These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

962 related items for PubMed ID: 10506254

  • 21. Combined use of growth hormone and gonadotropin-releasing hormone analogue in short normal adolescent girls: a survey from Iran.
    Karamizadeh Z, Kashef MA, Jalaeian H, Namazee N.
    Kaohsiung J Med Sci; 2006 Apr; 22(4):161-5. PubMed ID: 16679296
    [Abstract] [Full Text] [Related]

  • 22. Gonadotropin releasing hormone agonist treatment to increase final stature in children with precocious puberty: a meta-analysis.
    Li P, Li Y, Yang CL.
    Medicine (Baltimore); 2014 Dec; 93(27):e260. PubMed ID: 25501098
    [Abstract] [Full Text] [Related]

  • 23. [Impact of gonadotropin-releasing hormone analogs on body mass index in girls with idiopathic central precocious puberty: a long-term follow-up study].
    Yuan JN, Liang L, Cai XD, Li Z, Bai M, Gu CP.
    Zhongguo Dang Dai Er Ke Za Zhi; 2011 Nov; 13(11):896-9. PubMed ID: 22099200
    [Abstract] [Full Text] [Related]

  • 24. Precocious puberty and statural growth.
    Carel JC, Lahlou N, Roger M, Chaussain JL.
    Hum Reprod Update; 2004 Nov; 10(2):135-47. PubMed ID: 15073143
    [Abstract] [Full Text] [Related]

  • 25. Adult height in growth hormone deficiency: historical perspective and examples from the national cooperative growth study.
    Frindik JP, Baptista J.
    Pediatrics; 1999 Oct; 104(4 Pt 2):1000-4. PubMed ID: 10506251
    [Abstract] [Full Text] [Related]

  • 26. The Beneficial Effect of Combined GH/GnRHa Therapy in Increasing Adult Height Outcome in Children With ISS.
    Lazar L, Levy S, Oron T, Meyerovitch J, de Vries L, Shalitin S, Tenenbaum A, Phillip M, Lebenthal Y.
    J Clin Endocrinol Metab; 2019 Aug 01; 104(8):3287-3295. PubMed ID: 30912806
    [Abstract] [Full Text] [Related]

  • 27. Consensus statement on the use of gonadotropin-releasing hormone analogs in children.
    Carel JC, Eugster EA, Rogol A, Ghizzoni L, Palmert MR, ESPE-LWPES GnRH Analogs Consensus Conference Group, Antoniazzi F, Berenbaum S, Bourguignon JP, Chrousos GP, Coste J, Deal S, de Vries L, Foster C, Heger S, Holland J, Jahnukainen K, Juul A, Kaplowitz P, Lahlou N, Lee MM, Lee P, Merke DP, Neely EK, Oostdijk W, Phillip M, Rosenfield RL, Shulman D, Styne D, Tauber M, Wit JM.
    Pediatrics; 2009 Apr 01; 123(4):e752-62. PubMed ID: 19332438
    [Abstract] [Full Text] [Related]

  • 28. [Effect of treatment with gonadotropin releasing hormone analogues in girls with idiopathic central precocious puberty].
    Ságodi L, Sólyom E, Lombay B, Almási A, Vámosi I.
    Orv Hetil; 2012 Mar 18; 153(11):418-24. PubMed ID: 22390866
    [Abstract] [Full Text] [Related]

  • 29. A brief review of the addition of gonadotropin-releasing hormone agonists (GnRH-Ag) to growth hormone (GH) treatment of children with idiopathic growth hormone deficiency: Previously published studies from America.
    Reiter EO.
    Mol Cell Endocrinol; 2006 Jul 25; 254-255():221-5. PubMed ID: 16787696
    [Abstract] [Full Text] [Related]

  • 30. Effect of long-term growth hormone therapy on bone age and pubertal maturation in boys with and without classic growth hormone deficiency.
    Zadik Z, Chalew S, Zung A, Landau H, Leiberman E, Koren R, Voet H, Hochberg Z, Kowarski AA.
    J Pediatr; 1994 Aug 25; 125(2):189-95. PubMed ID: 8040760
    [Abstract] [Full Text] [Related]

  • 31. Expensive therapies in children: benefit versus cost of combined treatment of recombinant human growth hormone and gonadotropin-releasing hormone analogue in girls with poor height potential.
    Toumba M, Kokotsis V, Savva SC, Skordis N.
    J Pediatr Endocrinol Metab; 2014 Mar 25; 27(3-4):311-6. PubMed ID: 24158419
    [Abstract] [Full Text] [Related]

  • 32. Final height after combined growth hormone and GnRH analogue treatment in adopted girls with early puberty.
    Tuvemo T, Jonsson B, Gustafsson J, Albertsson-Wikland K, Aronson AS, Häger A, Ivarson S, Kriström B, Marcus C, Nilsson KO, Westgren U, Westphal O, Aman J, Proos LA.
    Acta Paediatr; 2004 Nov 25; 93(11):1456-62. PubMed ID: 15513572
    [Abstract] [Full Text] [Related]

  • 33. Adult height in short children born SGA treated with growth hormone and gonadotropin releasing hormone analog: results of a randomized, dose-response GH trial.
    Lem AJ, van der Kaay DC, de Ridder MA, Bakker-van Waarde WM, van der Hulst FJ, Mulder JC, Noordam C, Odink RJ, Oostdijk W, Schroor EJ, Sulkers EJ, Westerlaken C, Hokken-Koelega AC.
    J Clin Endocrinol Metab; 2012 Nov 25; 97(11):4096-105. PubMed ID: 22904179
    [Abstract] [Full Text] [Related]

  • 34. [Effect of gonadotropin-releasing hormone analog combined with stanazolol on final height in girls with idiopathic central precocious puberty and apparent decrease of linear growth].
    Li YH, Zhu SY, Ma HM, Su Z, Chen HS, Chen QL, Gu YF, Du ML.
    Zhonghua Er Ke Za Zhi; 2013 Nov 25; 51(11):807-12. PubMed ID: 24484553
    [Abstract] [Full Text] [Related]

  • 35. Low growth hormone levels are related to increased body mass index and do not reflect impaired growth in luteinizing hormone-releasing hormone agonist-treated children with precocious puberty.
    Kamp GA, Manasco PK, Barnes KM, Jones J, Rose SR, Hill SC, Cutler GB.
    J Clin Endocrinol Metab; 1991 Feb 25; 72(2):301-7. PubMed ID: 1991801
    [Abstract] [Full Text] [Related]

  • 36. The KIGS experience with the addition of gonadotropin-releasing hormone agonists to growth hormone (GH) treatment of children with idiopathic GH deficiency.
    Reiter EO, Lindberg A, Ranke MB, Price DA, Albertsson-Wikland K, Cowell CT, Bakker B.
    Horm Res; 2003 Feb 25; 60(Suppl 1):68-73. PubMed ID: 12955021
    [Abstract] [Full Text] [Related]

  • 37. A Critical Appraisal of the Effect of Gonadotropin-Releasing Hormon Analog Treatment on Adult Height of Girls with Central Precocious Puberty.
    Bereket A.
    J Clin Res Pediatr Endocrinol; 2017 Dec 30; 9(Suppl 2):33-48. PubMed ID: 29280737
    [Abstract] [Full Text] [Related]

  • 38. [Evaluation of final height in patients with pituitary growth hormone deficiency who were treated with growth hormone replacement].
    Korpal-Szczyrska M, Dorant B, Kamińska H, Birkholz D, Niedźwiecki M.
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006 Dec 30; 12(1):31-4. PubMed ID: 16704859
    [Abstract] [Full Text] [Related]

  • 39. Growth hormone therapy alone or in combination with gonadotropin-releasing hormone analog therapy to improve the height deficit in children with congenital adrenal hyperplasia.
    Quintos JB, Vogiatzi MG, Harbison MD, New MI.
    J Clin Endocrinol Metab; 2001 Apr 30; 86(4):1511-7. PubMed ID: 11297576
    [Abstract] [Full Text] [Related]

  • 40. Final height outcome after three years of growth hormone and gonadotropin-releasing hormone agonist treatment in short adolescents with relatively early puberty.
    van Gool SA, Kamp GA, Visser-van Balen H, Mul D, Waelkens JJ, Jansen M, Verhoeven-Wind L, Delemarre-van de Waal HA, de Muinck Keizer-Schrama SM, Leusink G, Roos JC, Wit JM.
    J Clin Endocrinol Metab; 2007 Apr 30; 92(4):1402-8. PubMed ID: 17284626
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 49.